Prostate cancer genomics: towards a new understanding

Recent genetics and genomics studies of prostate cancer have helped to clarify the genetic basis of this common but complex disease. Genome-wide studies have detected numerous variants associated with disease as well as common gene fusions and expression 'signatures' in prostate tumours. On the basis of these results, some advocate gene-based individualized screening for prostate cancer, although such testing might only be worthwhile to distinguish disease aggressiveness. Lessons learned from these studies provide strategies for further deciphering the genetic causes of prostate cancer and other diseases.

[1]  T. Golub,et al.  Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. , 2008, Journal of the National Cancer Institute.

[2]  J. Tchinda,et al.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.

[3]  D. Gudbjartsson,et al.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes , 2007, Nature Genetics.

[4]  J. Witte.  Multiple prostate cancer risk variants on 8q24 , 2007, Nature Genetics.

[5]  A. Whittemore,et al.  Where are the prostate cancer genes?—A summary of eight genome wide searches , 2003, The Prostate.

[6]  J. Ware.  The limitations of risk factors as prognostic tools. , 2006, The New England journal of medicine.

[7]  W. Willett,et al.  Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.

[8]  J. Brooks.  Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer , 2008 .

[9]  Pär Stattin,et al.  Cumulative association of five genetic variants with prostate cancer. , 2008, The New England journal of medicine.

[10]  S. Srivastava,et al.  TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation , 2008, Oncogene.

[11]  S. Dhanasekaran,et al.  Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.

[12]  David Reich,et al.  A common genetic risk factor for colorectal and prostate cancer , 2007, Nature Genetics.

[13]  A. Whittemore,et al.  Multiple regions within 8q24 independently affect risk for prostate cancer , 2007, Nature Genetics.

[14]  P. Kantoff,et al.  Testing a Multigene Signature of Prostate Cancer Death in the Swedish Watchful Waiting Cohort , 2008, Cancer Epidemiology Biomarkers & Prevention.

[15]  D. English,et al.  The Common Variant rs1447295 on Chromosome 8q24 and Prostate Cancer Risk: Results from an Australian Population-Based Case-Control Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[16]  J. Witte,et al.  Genome-wide association studies of cancer. , 2007, Future oncology.

[17]  J. Cuzick,et al.  Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer , 2008, British Journal of Cancer.

[18]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[19]  Steven Gallinger,et al.  Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24 , 2007, Nature Genetics.

[20]  J. Cerhan,et al.  Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. , 2007, Cancer research.

[21]  Tony Fletcher,et al.  Sequence variant on 8q24 confers susceptibility to urinary bladder cancer , 2008, Nature Genetics.

[22]  J. Carpten,et al.  Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. , 2007, Journal of the National Cancer Institute.

[23]  D. Gudbjartsson,et al.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 , 2007, Nature Genetics.

[24]  A. Nobel,et al.  Concordance among Gene-Expression – Based Predictors for Breast Cancer , 2011 .

[25]  A. Kibel.  Multiple newly identified loci associated with prostate cancer susceptibility , 2009 .

[26]  J. Witte,et al.  Genetic dissection of complex traits , 1996, Nature Genetics.

[27]  Michael C O'Donovan,et al.  Strong bias in the location of functional promoter polymorphisms , 2005, Human mutation.

[28]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[29]  R. Shah,et al.  Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer. , 2008, Cancer research.

[30]  J. Witte,et al.  8q24 and prostate cancer: association with advanced disease and meta-analysis , 2008, European Journal of Human Genetics.

[31]  D. Schaid,et al.  Confirmation of a Positive Association between Prostate Cancer Risk and a Locus at Chromosome 8q24 , 2007, Cancer Epidemiology Biomarkers & Prevention.

[32]  P. Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.

[33]  Peter Kraft,et al.  A common 8q24 variant in prostate and breast cancer from a large nested case-control study. , 2007, Cancer research.

[34]  Daniel J Schaid,et al.  The complex genetic epidemiology of prostate cancer. , 2004, Human molecular genetics.

[35]  John L Hopper,et al.  Multiple loci with different cancer specificities within the 8q24 gene desert. , 2008, Journal of the National Cancer Institute.

[36]  Elaine A. Ostrander,et al.  Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium , 2008, Cancer Epidemiology Biomarkers & Prevention.

[37]  J. Uhm.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2009 .

[38]  M. Bollen,et al.  The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2 , 2007, Oncogene.

[39]  T. Shaikh,et al.  A palindrome-mediated mechanism distinguishes translocations involving LCR-B of chromosome 22q11.2. , 2004, Human molecular genetics.

[40]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[41]  A. Whittemore,et al.  Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men , 2006, Proceedings of the National Academy of Sciences.

[42]  J. Carpten,et al.  Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans , 2008, The Prostate.

[43]  M. Bissell.  A First-Generation Multiplex Biomarker Analysis of Urine For The Early Detection of Prostate Cancer , 2009 .

[44]  Gary K. Chen,et al.  Enriching the analysis of genomewide association studies with hierarchical modeling. , 2007, American journal of human genetics.

[45]  Yu Cheng,et al.  Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. , 2007, Journal of the National Cancer Institute.

[46]  A. Chinnaiyan,et al.  Recurrent gene fusions in prostate cancer , 2008, Nature Reviews Cancer.

[47]  Adam S. Kibel,et al.  A common variant associated with prostate cancer in European and African populations , 2007 .

[48]  C. D. Savci-Heijink,et al.  Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  Andrew J. Vickers,et al.  Prostate-specific antigen and prostate cancer: prediction, detection and monitoring , 2008, Nature Reviews Cancer.